Literature DB >> 7534404

Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.

B D Bennett1, F C Zeigler, Q Gu, B Fendly, A D Goddard, N Gillett, W Matthews.   

Abstract

Htk is a receptor protein-tyrosine kinase that is related to the EPH subfamily of tyrosine kinases. The receptor has a wide tissue distribution including expression in several myeloid hematopoietic cell lines. Using an Htk-Fc fusion protein, a protein ligand for this receptor was expression cloned from the murine kidney mesangial cell line SV40MES 13. The Htk ligand cDNA encodes a transmembrane protein of 336 amino acids. Binding competition experiments demonstrated a Kd of 535 pM for binding of Htk-Fc to the Htk ligand. Incubation of 3T3 cells expressing Htk with COS-7 cells expressing the ligand resulted in tyrosine phosphorylation of Htk. The ligand, like its receptor, is widely expressed and may function in a variety of tissues. However, we localized hematopoietic expression of Htk to the monocytic lineage, suggesting that the ligand may play a role in differentiation and/or proliferation of these cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534404      PMCID: PMC42383          DOI: 10.1073/pnas.92.6.1866

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Cellular and developmental properties of fetal hematopoietic stem cells.

Authors:  C T Jordan; J P McKearn; I R Lemischka
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

Review 2.  Receptor tyrosine kinases: genetic evidence for their role in Drosophila and mouse development.

Authors:  T Pawson; A Bernstein
Journal:  Trends Genet       Date:  1990-11       Impact factor: 11.639

3.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

4.  Affinity purification and chemical analysis of the interleukin-1 receptor.

Authors:  D L Urdal; S M Call; J L Jackson; S K Dower
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Characterization of elk, a brain-specific receptor tyrosine kinase.

Authors:  V Lhoták; P Greer; K Letwin; T Pawson
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

7.  Structure and functional expression of a human interleukin-8 receptor.

Authors:  W E Holmes; J Lee; W J Kuang; G C Rice; W I Wood
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

8.  CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Authors:  C A Smith; H J Gruss; T Davis; D Anderson; T Farrah; E Baker; G R Sutherland; C I Brannan; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

9.  Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice.

Authors:  K MacKay; L J Striker; S Elliot; C A Pinkert; R L Brinster; G E Striker
Journal:  Kidney Int       Date:  1988-03       Impact factor: 10.612

10.  Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.

Authors:  D P Gearing; J A King; N M Gough; N A Nicola
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  14 in total

1.  The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.

Authors:  J P Labrador; R Brambilla; R Klein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

2.  Shared and distinct functions of RAGS and ELF-1 in guiding retinal axons.

Authors:  B Monschau; C Kremoser; K Ohta; H Tanaka; T Kaneko; T Yamada; C Handwerker; M R Hornberger; J Löschinger; E B Pasquale; D A Siever; M F Verderame; B K Müller; F Bonhoeffer; U Drescher
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 3.  Molecular identity of arteries, veins, and lymphatics.

Authors:  Katharine Wolf; Haidi Hu; Toshihiko Isaji; Alan Dardik
Journal:  J Vasc Surg       Date:  2018-08-25       Impact factor: 4.268

4.  Control of blood vessel identity: from embryo to adult.

Authors:  Tiffany T Fancher; Akihito Muto; Tamara N Fitzgerald; Dania Magri; David Gortler; Toshiya Nishibe; Alan Dardik
Journal:  Ann Vasc Dis       Date:  2008-02-15

5.  Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5.

Authors:  M D Wilson; C Riemer; D W Martindale; P Schnupf; A P Boright; T L Cheung; D M Hardy; S Schwartz; S W Scherer; L C Tsui; W Miller; B F Koop
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

6.  Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy.

Authors:  Satya Vani Guttula; Allam Appa Rao; G R Sridhar; M S Chakravarthy; Kunjum Nageshwararo; Paturi V Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

Review 7.  Membrane-mediated regulation of vascular identity.

Authors:  Takuya Hashimoto; Masayuki Tsuneki; Trenton R Foster; Jeans M Santana; Hualong Bai; Mo Wang; Haidi Hu; Jesse J Hanisch; Alan Dardik
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17

8.  Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Authors:  Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

9.  Tyr-298 in ephrinB1 is critical for an interaction with the Grb4 adaptor protein.

Authors:  Yong-Sik Bong; Yeon-Hwa Park; Hyun-Shik Lee; Kathleen Mood; Akihiko Ishimura; Ira O Daar
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

10.  The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.

Authors:  Anne M Galea; Vincent Murray
Journal:  Cancer Inform       Date:  2008-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.